|
G |
A2M |
alpha-2-macroglobulin |
increases uptake multiple interactions |
EXP |
A2M protein modified form results in increased uptake of Deoxyglucose HSPA5 protein affects the reaction [A2M protein modified form results in increased uptake of Deoxyglucose] |
CTD |
PMID:25720493 |
|
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [ABCB1 protein results in increased export of Diazinon] |
CTD |
PMID:16221533 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCC9 |
ATP binding cassette subfamily C member 9 |
multiple interactions |
ISO |
[Oligomycins co-treated with Deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein]; Glyburide inhibits the reaction [[Oligomycins co-treated with Deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein]] |
CTD |
PMID:28842488 |
|
NCBI chr12:21,797,389...21,941,426
Ensembl chr12:21,797,389...21,942,543
|
|
G |
ABRA |
actin binding Rho activating protein |
multiple interactions increases uptake |
ISO |
CCG 1423 promotes the reaction [ABRA mutant form promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; CCG 1423 promotes the reaction [ABRA mutant form results in increased uptake of Deoxyglucose]; CCG 1423 promotes the reaction [INS1 protein promotes the reaction [ABRA mutant form results in increased uptake of Deoxyglucose]]; INS1 protein promotes the reaction [ABRA mutant form results in increased uptake of Deoxyglucose] |
CTD |
PMID:21393865 |
|
NCBI chr 8:106,759,483...106,770,244
Ensembl chr 8:106,759,483...106,770,244
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
multiple interactions increases uptake |
EXP |
Indinavir inhibits the reaction [ADIPOQ protein modified form results in increased uptake of Deoxyglucose] |
CTD |
PMID:29991592 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
AGRP |
agouti related neuropeptide |
increases expression |
ISO |
Deoxyglucose results in increased expression of AGRP mRNA |
CTD |
PMID:10683841 |
|
NCBI chr16:67,482,571...67,483,547
Ensembl chr16:67,482,571...67,483,547
|
|
G |
AP5S1 |
adaptor related protein complex 5 subunit sigma 1 |
increases expression |
EXP |
Deoxyglucose results in increased expression of AP5S1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr20:3,820,547...3,828,838
Ensembl chr20:3,820,524...3,828,838
|
|
G |
APP |
amyloid beta precursor protein |
multiple interactions |
EXP |
[Sodium Azide co-treated with Deoxyglucose] affects the cleavage of and affects the localization of APP protein |
CTD |
PMID:17405930 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
ATG3 |
autophagy related 3 |
multiple interactions |
EXP |
Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of ATG3 mRNA] |
CTD |
PMID:26079942 |
|
NCBI chr 3:112,532,510...112,561,962
Ensembl chr 3:112,532,510...112,562,046
|
|
G |
ATG4B |
autophagy related 4B cysteine peptidase |
multiple interactions |
EXP |
[demycarosyl-3D-digitoxosylmithramycin SK co-treated with Deoxyglucose] results in increased expression of ATG4B mRNA |
CTD |
PMID:26079942 |
|
NCBI chr 2:241,637,693...241,673,857
Ensembl chr 2:241,637,213...241,673,857
|
|
G |
ATG7 |
autophagy related 7 |
multiple interactions |
EXP |
ATG7 protein inhibits the reaction [Deoxyglucose results in increased cleavage of CASP3 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of DDIT3 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; ATG7 protein promotes the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] |
CTD |
PMID:20593179 |
|
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions decreases expression |
EXP |
Deoxyglucose promotes the reaction [arsenic trioxide results in increased localization of and results in increased activity of BAX protein]; Deoxyglucose results in increased localization of and results in increased activity of BAX protein Deoxyglucose results in decreased expression of BAX mRNA |
CTD |
PMID:23041229 PMID:26079942 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP |
Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of BCL2 mRNA] |
CTD |
PMID:26079942 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases response to substance |
ISO |
BCL2L1 protein results in decreased susceptibility to Deoxyglucose |
CTD |
PMID:10679475 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BECN1 |
beclin 1 |
multiple interactions |
EXP |
[bafilomycin A co-treated with Deoxyglucose co-treated with demycarosyl-3D-digitoxosylmithramycin SK] results in decreased expression of BECN1 protein; [demycarosyl-3D-digitoxosylmithramycin SK co-treated with Deoxyglucose] results in increased expression of BECN1 mRNA |
CTD |
PMID:26079942 |
|
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
BID |
BH3 interacting domain death agonist |
multiple interactions |
EXP |
Deoxyglucose promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of BID protein]; Deoxyglucose results in increased cleavage of and results in increased activity of BID protein |
CTD |
PMID:23041229 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity increases cleavage |
EXP ISO |
ATG7 protein inhibits the reaction [Deoxyglucose results in increased cleavage of CASP3 protein]; Deoxyglucose promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP3 protein]; Deoxyglucose results in increased cleavage of and results in increased activity of CASP3 protein Deoxyglucose promotes the reaction [Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]] Deoxyglucose results in increased activity of CASP3 protein Corticosterone inhibits the reaction [Deoxyglucose results in increased activity of CASP3 protein]; GPX4 protein inhibits the reaction [Deoxyglucose results in increased activity of CASP3 protein] |
CTD |
PMID:10506188 PMID:15755911 PMID:20593179 PMID:23041229 PMID:29095437 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
[Deoxyglucose co-treated with Cisplatin] results in increased activity of CASP9 protein; Deoxyglucose promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP9 protein]; Deoxyglucose results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:20138251 PMID:23041229 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CCDC144NL |
CCDC144A N-terminal like (pseudogene) |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of CCDC144NL mRNA |
CTD |
PMID:33770205 |
|
NCBI chr17:20,863,395...20,896,163
Ensembl chr17:20,836,447...20,896,162 Ensembl chr17:20,836,447...20,896,162
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
EXP |
[demycarosyl-3D-digitoxosylmithramycin SK co-treated with Deoxyglucose] results in increased expression of CDKN1A mRNA |
CTD |
PMID:26079942 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CEMIP2 |
cell migration inducing hyaluronidase 2 |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of CEMIP2 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 9:71,683,366...71,769,466
Ensembl chr 9:71,683,366...71,816,690
|
|
G |
CHRM3 |
cholinergic receptor muscarinic 3 |
affects response to substance |
ISO |
CHRM3 protein affects the susceptibility to Deoxyglucose |
CTD |
PMID:14724830 |
|
NCBI chr 1:239,386,568...239,915,450
Ensembl chr 1:239,386,565...239,915,452
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
affects localization |
EXP |
Deoxyglucose analog affects the localization of CHUK protein |
CTD |
PMID:27931795 |
|
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
G |
CTSD |
cathepsin D |
increases expression |
ISO |
Deoxyglucose results in increased expression of CTSD protein |
CTD |
PMID:20026095 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
CTSLP8 |
cathepsin L pseudogene 8 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [CTSLP8 protein results in decreased susceptibility to Cisplatin]; Deoxyglucose inhibits the reaction [CTSLP8 protein results in increased chemical synthesis of Lactic Acid] |
CTD |
PMID:34510316 |
|
NCBI chr 9:87,844,745...87,847,424
Ensembl chr 9:87,844,154...87,847,314
|
|
G |
CUL7 |
cullin 7 |
multiple interactions |
ISO |
[INS1 protein co-treated with CUL7 mutant form] results in increased uptake of Deoxyglucose |
CTD |
PMID:24219910 |
|
NCBI chr 6:43,037,617...43,053,851
Ensembl chr 6:43,037,617...43,053,943
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions increases expression |
EXP |
ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of DDIT3 protein]; Mannose inhibits the reaction [Deoxyglucose results in increased expression of DDIT3 protein] |
CTD |
PMID:20593179 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions increases import |
EXP |
AICA ribonucleotide inhibits the reaction [EGFR protein results in increased import of Deoxyglucose] EGFR protein mutant form results in increased import of Deoxyglucose |
CTD |
PMID:19625624 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
EXP |
Deoxyglucose results in decreased phosphorylation of and results in increased expression of EIF4EBP1 protein |
CTD |
PMID:23363784 |
|
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
|
|
G |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
EXP |
[Deoxyglucose co-treated with Quercetin] results in increased ubiquitination of ERBB2 protein; Deoxyglucose inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] |
CTD |
PMID:18655187 |
|
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
|
|
G |
ERRFI1 |
ERBB receptor feedback inhibitor 1 |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of ERRFI1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 1:8,011,727...8,026,309
Ensembl chr 1:8,004,404...8,026,309
|
|
G |
FAM117A |
family with sequence similarity 117 member A |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of FAM117A mRNA |
CTD |
PMID:33770205 |
|
NCBI chr17:49,710,332...49,789,110
Ensembl chr17:49,710,332...49,789,180
|
|
G |
FXYD2 |
FXYD domain containing ion transport regulator 2 |
multiple interactions increases transport |
EXP |
Calcium inhibits the reaction [FXYD2 protein results in increased transport of Deoxyglucose] |
CTD |
PMID:11533133 |
|
NCBI chr11:117,820,057...117,828,089
Ensembl chr11:117,800,844...117,828,698
|
|
G |
G3BP1 |
G3BP stress granule assembly factor 1 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [G3BP1 protein results in increased abundance of Lactic Acid]; Deoxyglucose inhibits the reaction [G3BP1 protein results in increased expression of HK2 protein]; Deoxyglucose inhibits the reaction [G3BP1 protein results in increased expression of LDHA protein]; Deoxyglucose inhibits the reaction [G3BP1 protein results in increased expression of PKM protein]; Deoxyglucose inhibits the reaction [G3BP1 protein results in increased uptake of Glucose] |
CTD |
PMID:35945655 |
|
NCBI chr 5:151,771,954...151,812,785
Ensembl chr 5:151,771,045...151,812,911
|
|
G |
GALR1 |
galanin receptor 1 |
increases expression |
ISO |
Deoxyglucose results in increased expression of GALR1 mRNA |
CTD |
PMID:9858361 PMID:9928191 |
|
NCBI chr18:77,249,848...77,277,900
Ensembl chr18:77,249,848...77,277,900
|
|
G |
GCG |
glucagon |
multiple interactions increases secretion |
ISO |
Capsaicin inhibits the reaction [Deoxyglucose results in increased secretion of GCG protein] |
CTD |
PMID:1378463 |
|
NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404
|
|
G |
GPX4 |
glutathione peroxidase 4 |
multiple interactions |
ISO |
GPX4 protein inhibits the reaction [Deoxyglucose results in increased activity of CASP3 protein] |
CTD |
PMID:10506188 |
|
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [arsenic trioxide results in increased phosphorylation of GSK3B protein]; Deoxyglucose inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:25246272 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
H2AX |
H2A.X variant histone |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of H2AX protein |
CTD |
PMID:23363784 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
HK2 |
hexokinase 2 |
multiple interactions |
EXP |
[Lactic Acid co-treated with Deoxyglucose] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HK2 protein]; Deoxyglucose inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HK2 protein]; Deoxyglucose inhibits the reaction [G3BP1 protein results in increased expression of HK2 protein]; Deoxyglucose inhibits the reaction [HMGA2 protein results in increased expression of HK2 protein]; Deoxyglucose results in decreased expression of and results in decreased activity of HK2 protein |
CTD |
PMID:32619556 PMID:34481905 PMID:35945655 PMID:36336208 |
|
NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359
|
|
G |
HMGA2 |
high mobility group AT-hook 2 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [HMGA2 protein results in decreased expression of COX4 protein]; Deoxyglucose inhibits the reaction [HMGA2 protein results in decreased expression of ND1 protein]; Deoxyglucose inhibits the reaction [HMGA2 protein results in increased expression of HK2 protein]; Deoxyglucose inhibits the reaction [HMGA2 protein results in increased expression of MMP2 protein]; Deoxyglucose inhibits the reaction [HMGA2 protein results in increased expression of MMP9 protein] |
CTD |
PMID:34481905 |
|
NCBI chr12:65,824,460...65,966,291
Ensembl chr12:65,824,460...65,966,291
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [arsenic trioxide results in increased expression of HMOX1 protein]; Deoxyglucose inhibits the reaction [Fenretinide results in increased expression of HMOX1 protein] |
CTD |
PMID:25246272 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HSP90AA1 |
heat shock protein 90 alpha family class A member 1 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] |
CTD |
PMID:18655187 |
|
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
multiple interactions increases expression |
EXP |
4-Quinolones analog inhibits the reaction [Deoxyglucose results in increased expression of HSP90B1 protein] |
CTD |
PMID:31022492 |
|
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
EXP |
4-Quinolones analog inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 mRNA]; 4-Quinolones analog inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; HSPA5 protein affects the reaction [A2M protein modified form results in increased uptake of Deoxyglucose]; HSPA5 protein affects the reaction [INS protein results in increased uptake of Deoxyglucose]; Mannose inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein] Deoxyglucose results in increased expression of HSPA5 mRNA; Deoxyglucose results in increased expression of HSPA5 protein |
CTD |
PMID:20593179 PMID:25720493 PMID:31022492 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HTRA2 |
HtrA serine peptidase 2 |
multiple interactions decreases localization |
EXP |
Deoxyglucose promotes the reaction [arsenic trioxide results in decreased localization of HTRA2 protein] Deoxyglucose results in decreased localization of HTRA2 protein |
CTD |
PMID:23041229 |
|
NCBI chr 2:74,529,405...74,533,556
Ensembl chr 2:74,529,596...74,533,350
|
|
G |
IGF1R |
insulin like growth factor 1 receptor |
multiple interactions |
EXP |
Deoxyglucose results in increased phosphorylation of and results in increased activity of IGF1R protein |
CTD |
PMID:23041229 |
|
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
|
|
G |
IL1B |
interleukin 1 beta |
decreases response to substance multiple interactions |
EXP ISO |
Deoxyglucose results in decreased susceptibility to IL1B protein Deoxyglucose inhibits the reaction [bisphenol F results in increased secretion of IL1B protein] Deoxyglucose inhibits the reaction [IL1B protein results in increased expression of MMP13 protein] |
CTD |
PMID:21211511 PMID:34147605 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
Deoxyglucose inhibits the reaction [bisphenol F results in increased secretion of IL6 protein] |
CTD |
PMID:34147605 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS |
insulin |
increases uptake multiple interactions |
EXP ISO |
INS protein results in increased uptake of Deoxyglucose; INS results in increased uptake of Deoxyglucose METRNL protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; PPARA protein promotes the reaction [GW 7647 promotes the reaction [INS protein results in increased uptake of Deoxyglucose]] 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]; 4-phenylbutyric acid inhibits the reaction [Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]]; Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]; GW 7647 promotes the reaction [INS protein results in increased uptake of Deoxyglucose]; HSPA5 protein affects the reaction [INS protein results in increased uptake of Deoxyglucose]; Palmitates inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; SLC2A1 protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]]; TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]; ursodoxicoltaurine inhibits the reaction [Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]] |
CTD |
PMID:2173694 PMID:16483873 PMID:20165829 PMID:21324916 PMID:25720493 PMID:25815690 PMID:30213948 PMID:31877369 More...
|
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
increases uptake increases secretion affects transport increases transport multiple interactions |
ISO |
INS1 protein results in increased uptake of Deoxyglucose; INS1 results in increased uptake of Deoxyglucose Deoxyglucose results in increased secretion of INS1 protein INS1 protein affects the transport of Deoxyglucose INS1 protein results in increased transport of Deoxyglucose 4-phenylbutyric acid inhibits the reaction [Glucosamine inhibits the reaction [INS1 results in increased uptake of Deoxyglucose]]; CCG 1423 promotes the reaction [ABRA mutant form promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; CCG 1423 promotes the reaction [INS1 protein promotes the reaction [ABRA mutant form results in increased uptake of Deoxyglucose]]; CCG 1423 promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Diethylhexyl Phthalate inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Glucosamine inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Glucosamine inhibits the reaction [INS1 results in increased uptake of Deoxyglucose]; Glucose inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; glyceryl 2-arachidonate promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]; INS1 protein promotes the reaction [ABRA mutant form results in increased uptake of Deoxyglucose]; INS1 protein promotes the reaction [CCG 1423 results in increased uptake of Deoxyglucose]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [glyceryl 2-arachidonate promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; oxophenylarsine inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Quercetin inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; Quercetin inhibits the reaction [TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; Quercetin promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Raffinose promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]; SLC2A4 promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]; TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; ursodoxicoltaurine inhibits the reaction [Glucosamine inhibits the reaction [INS1 results in increased uptake of Deoxyglucose]] [INS1 protein co-treated with CUL7 mutant form] results in increased uptake of Deoxyglucose; acetylaminophenylarsine oxide inhibits the reaction [INS1 protein results in increased transport of Deoxyglucose]; Apigenin inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS1 protein results in increased transport of Deoxyglucose]]; Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; Dimercaprol inhibits the reaction [p-aminophenylarsine oxide inhibits the reaction [INS1 protein results in increased transport of Deoxyglucose]]; dorsomorphin inhibits the reaction [Quercetin inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; epigallocatechin gallate inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; fisetin inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Genistein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Genistein inhibits the reaction [Raffinose promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; kaempferol inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Luteolin inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; oxophenylarsine inhibits the reaction [INS1 protein results in increased transport of Deoxyglucose]; oxophenylarsine inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; p-aminophenylarsine oxide inhibits the reaction [INS1 protein results in increased transport of Deoxyglucose]; Quercetin inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Quercetin inhibits the reaction [TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; Raffinose promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Ro 31-8220 inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Silybin inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; theaflavin inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; tyrphostin 25 inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Wortmannin inhibits the reaction [Raffinose promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]] |
CTD |
PMID:1378463 PMID:1536656 PMID:1847587 PMID:1918056 PMID:2202293 PMID:2877896 PMID:3882699 PMID:9453242 PMID:14511371 PMID:18591783 PMID:20165829 PMID:20206685 PMID:21393865 PMID:22713545 PMID:23439570 PMID:24219910 PMID:24287560 PMID:24343960 PMID:26627467 PMID:28298333 PMID:28526321 PMID:29458019 PMID:31408376 More...
|
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
ITGB1 |
integrin subunit beta 1 |
decreases expression |
EXP |
Deoxyglucose analog results in decreased expression of ITGB1 protein |
CTD |
PMID:27931795 |
|
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
|
|
G |
JADE2 |
jade family PHD finger 2 |
increases expression |
EXP |
Deoxyglucose results in increased expression of JADE2 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 5:134,523,952...134,583,227
Ensembl chr 5:134,524,312...134,583,230
|
|
G |
KCNH2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions decreases activity |
EXP |
[Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein; Deoxyglucose inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]; Deoxyglucose promotes the reaction [Glucose deficiency results in decreased activity of KCNH2 protein]; Pyruvic Acid inhibits the reaction [[Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein] Deoxyglucose results in decreased activity of KCNH2 protein |
CTD |
PMID:12531891 |
|
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
|
|
G |
KCNJ11 |
potassium inwardly rectifying channel subfamily J member 11 |
multiple interactions |
ISO |
[Oligomycins co-treated with Deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein]; Glyburide inhibits the reaction [[Oligomycins co-treated with Deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein]] |
CTD |
PMID:28842488 |
|
NCBI chr11:17,385,248...17,389,346
Ensembl chr11:17,365,172...17,389,331
|
|
G |
KLHL42 |
kelch like family member 42 |
increases expression |
EXP |
Deoxyglucose results in increased expression of KLHL42 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr12:27,780,233...27,803,040
Ensembl chr12:27,780,048...27,803,040
|
|
G |
LDHA |
lactate dehydrogenase A |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [G3BP1 protein results in increased expression of LDHA protein] |
CTD |
PMID:35945655 |
|
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
|
|
G |
LEP |
leptin |
multiple interactions decreases secretion |
ISO |
[Deoxyglucose results in decreased abundance of Adenosine Triphosphate] which results in decreased secretion of LEP protein Deoxyglucose results in decreased secretion of LEP protein |
CTD |
PMID:10780946 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LIPH |
lipase H |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of LIPH mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 3:185,506,262...185,552,588
Ensembl chr 3:185,506,262...185,552,588
|
|
G |
MAP1LC3A |
microtubule associated protein 1 light chain 3 alpha |
multiple interactions |
EXP |
Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of MAP1LC3A mRNA] |
CTD |
PMID:26079942 |
|
NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,854...34,560,345
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
multiple interactions increases prenylation |
EXP |
ATG7 protein promotes the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein]; Mannose inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein]; Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] |
CTD |
PMID:20593179 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
Arsenic Trioxide inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK1 protein; PQ 401 inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; U 0126 inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
CTD |
PMID:23041229 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO EXP |
MAPK3 protein affects the reaction [AICA ribonucleotide results in increased uptake of Deoxyglucose] arsenic trioxide inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK3 protein; PQ 401 inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; U 0126 inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:11978788 PMID:23041229 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MEPCE |
methylphosphate capping enzyme |
increases expression |
EXP |
Deoxyglucose results in increased expression of MEPCE mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 7:100,428,790...100,434,118
Ensembl chr 7:100,428,322...100,434,126
|
|
G |
METRNL |
meteorin like, glial cell differentiation regulator |
multiple interactions |
ISO |
METRNL protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose] |
CTD |
PMID:30213948 |
|
NCBI chr17:83,079,609...83,095,122
Ensembl chr17:83,079,609...83,095,122
|
|
G |
MMP13 |
matrix metallopeptidase 13 |
multiple interactions decreases expression |
EXP |
Deoxyglucose inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; Deoxyglucose inhibits the reaction [TNF protein results in increased expression of MMP13 protein] Deoxyglucose analog results in decreased expression of MMP13 protein |
CTD |
PMID:21211511 PMID:27931795 |
|
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP2 protein]; Deoxyglucose inhibits the reaction [HMGA2 protein results in increased expression of MMP2 protein] |
CTD |
PMID:34481905 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions |
EXP |
Deoxyglucose analog results in decreased expression of MMP9 protein Deoxyglucose inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP9 protein]; Deoxyglucose inhibits the reaction [HMGA2 protein results in increased expression of MMP9 protein] |
CTD |
PMID:27931795 PMID:34481905 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MT-ND1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in decreased expression of ND1 protein]; Deoxyglucose inhibits the reaction [HMGA2 protein results in decreased expression of ND1 protein] |
CTD |
PMID:34481905 |
|
NCBI chr MT:3,307...4,262
Ensembl chr MT:3,307...4,262
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions |
EXP |
Deoxyglucose results in decreased phosphorylation of and results in increased expression of MTOR protein; Deoxyglucose results in increased phosphorylation of and results in increased activity of MTOR protein |
CTD |
PMID:23041229 PMID:23363784 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
MXI1 |
MAX interactor 1, dimerization protein |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of MXI1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr10:110,207,605...110,287,365
Ensembl chr10:110,207,605...110,287,365
|
|
G |
MYO1E |
myosin IE |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of MYO1E mRNA |
CTD |
PMID:33770205 |
|
NCBI chr15:59,132,434...59,372,871
Ensembl chr15:59,132,434...59,372,871
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions decreases expression |
EXP |
[demycarosyl-3D-digitoxosylmithramycin SK co-treated with Deoxyglucose] affects the expression of NFKB1 mRNA Deoxyglucose results in decreased expression of NFKB1 mRNA |
CTD |
PMID:26079942 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Deoxyglucose promotes the reaction [STO 609 inhibits the reaction [Histamine results in increased phosphorylation of NOS2 protein]] |
CTD |
PMID:21145922 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NPY |
neuropeptide Y |
increases expression |
ISO |
Deoxyglucose results in increased expression of NPY mRNA |
CTD |
PMID:10683841 |
|
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
|
|
G |
OAT |
ornithine aminotransferase |
multiple interactions |
ISO |
Deoxyglucose inhibits the reaction [Cyclic AMP results in increased activity of OAT protein] |
CTD |
PMID:2827574 |
|
NCBI chr10:124,397,303...124,418,923
Ensembl chr10:124,397,303...124,418,976
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
EXP ISO |
Deoxyglucose inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]; Deoxyglucose inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] Deoxyglucose promotes the reaction [Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein modified form]] Deoxyglucose results in increased cleavage of PARP1 protein |
CTD |
PMID:25246272 PMID:29095437 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PKM |
pyruvate kinase M1/2 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [G3BP1 protein results in increased expression of PKM protein] |
CTD |
PMID:35945655 |
|
NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
|
|
G |
PMCH |
pro-melanin concentrating hormone |
increases expression |
ISO |
Deoxyglucose results in increased expression of PMCH mRNA |
CTD |
PMID:10683841 |
|
NCBI chr12:102,196,459...102,197,833
Ensembl chr12:102,196,459...102,197,833
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
PPARA protein promotes the reaction [GW 7647 promotes the reaction [INS protein results in increased uptake of Deoxyglucose]] |
CTD |
PMID:21324916 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
affects uptake increases uptake |
ISO |
PPARG protein affects the uptake of Deoxyglucose PPARG gene polymorphism results in increased uptake of Deoxyglucose |
CTD |
PMID:18083318 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPP3CA |
protein phosphatase 3 catalytic subunit alpha |
decreases response to substance |
ISO |
PPP3CA protein results in decreased susceptibility to Deoxyglucose |
CTD |
PMID:10679475 |
|
NCBI chr 4:101,023,418...101,347,526
Ensembl chr 4:101,023,409...101,348,278
|
|
G |
PYM1 |
PYM homolog 1, exon junction complex associated factor |
increases expression |
EXP |
Deoxyglucose results in increased expression of PYM1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr12:55,901,413...55,927,894
Ensembl chr12:55,901,413...55,932,618
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
RAF1 protein affects the reaction [AICA ribonucleotide results in increased uptake of Deoxyglucose] |
CTD |
PMID:11978788 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
|
|
G |
RNF24 |
ring finger protein 24 |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of RNF24 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr20:3,927,311...4,015,558
Ensembl chr20:3,927,309...4,015,558
|
|
G |
RPS6 |
ribosomal protein S6 |
decreases phosphorylation |
EXP |
Deoxyglucose results in decreased phosphorylation of RPS6 protein |
CTD |
PMID:23363784 |
|
NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,236
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation multiple interactions |
EXP |
Deoxyglucose results in decreased phosphorylation of RPS6KB1 protein Deoxyglucose results in increased phosphorylation of and results in increased activity of RPS6KB1 protein; oxophenylarsine inhibits the reaction [Deoxyglucose results in decreased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:16183647 PMID:23041229 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
SERPINB5 |
serpin family B member 5 |
increases expression |
EXP |
Deoxyglucose analog results in increased expression of SERPINB5 protein |
CTD |
PMID:27931795 |
|
NCBI chr18:63,476,958...63,505,085
Ensembl chr18:63,476,958...63,505,085
|
|
G |
SLC16A1 |
solute carrier family 16 member 1 |
multiple interactions |
EXP |
[Lactic Acid co-treated with Deoxyglucose] promotes the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC16A1 protein] |
CTD |
PMID:36336208 |
|
NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
multiple interactions increases uptake |
ISO EXP |
[arsenite affects the localization of SLC2A1 protein] which results in increased uptake of Deoxyglucose SLC2A1 protein results in increased uptake of Deoxyglucose [Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein; [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [[Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein]; SLC2A1 protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose] |
CTD |
PMID:2173694 PMID:14511371 PMID:31398423 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SLC2A2 |
solute carrier family 2 member 2 |
multiple interactions increases transport |
EXP |
Cytochalasin B inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose]; Fructose inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose]; Maltose inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose] |
CTD |
PMID:8457197 |
|
NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743
|
|
G |
SLC2A3 |
solute carrier family 2 member 3 |
multiple interactions increases transport |
EXP |
Cytochalasin B inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Galactose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] |
CTD |
PMID:8457197 |
|
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
|
|
G |
SLC2A4 |
solute carrier family 2 member 4 |
multiple interactions increases uptake |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]]; [arsenite affects the localization of SLC2A4 protein] which results in increased uptake of Deoxyglucose; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]; Plant Extracts promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose] [Indinavir results in decreased activity of SLC2A4 protein] inhibits the reaction [resveratrol results in increased uptake of Deoxyglucose]; SLC2A4 promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]; SLC2A4 protein promotes the reaction [resveratrol results in increased uptake of Deoxyglucose] |
CTD |
PMID:14511371 PMID:18601907 PMID:19477051 PMID:20206685 |
|
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
|
|
G |
SLC2A8 |
solute carrier family 2 member 8 |
increases uptake |
ISO |
SLC2A8 protein results in increased uptake of Deoxyglucose |
CTD |
PMID:23396969 |
|
NCBI chr 9:127,397,169...127,407,898
Ensembl chr 9:127,397,138...127,408,424
|
|
G |
SMIM14 |
small integral membrane protein 14 |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of SMIM14 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 4:39,546,336...39,638,865
Ensembl chr 4:39,546,336...39,638,902
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [manganese chloride results in increased expression of SOD2 mRNA]; Deoxyglucose inhibits the reaction [manganese chloride results in increased expression of SOD2 protein] |
CTD |
PMID:10328827 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SQSTM1 |
sequestosome 1 |
multiple interactions |
EXP |
[bafilomycin A co-treated with Deoxyglucose co-treated with demycarosyl-3D-digitoxosylmithramycin SK] affects the expression of SQSTM1 protein; [bafilomycin A co-treated with Deoxyglucose] affects the expression of SQSTM1 protein; Deoxyglucose inhibits the reaction [demycarosyl-3D-digitoxosylmithramycin SK results in decreased expression of SQSTM1 mRNA]; Deoxyglucose promotes the reaction [demycarosyl-3D-digitoxosylmithramycin SK results in decreased expression of SQSTM1 mRNA] |
CTD |
PMID:26079942 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
ISO |
Deoxyglucose results in increased expression of SREBF1 mRNA |
CTD |
PMID:10913129 |
|
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
|
|
G |
SRGAP3 |
SLIT-ROBO Rho GTPase activating protein 3 |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of SRGAP3 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 3:8,980,591...9,363,027
Ensembl chr 3:8,980,591...9,363,053
|
|
G |
STK11 |
serine/threonine kinase 11 |
decreases phosphorylation |
EXP |
Deoxyglucose results in decreased phosphorylation of STK11 protein |
CTD |
PMID:23041229 |
|
NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431
|
|
G |
TENT4B |
terminal nucleotidyltransferase 4B |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of TENT4B mRNA |
CTD |
PMID:33770205 |
|
NCBI chr16:50,152,911...50,235,310
Ensembl chr16:50,152,911...50,235,310
|
|
G |
TMCC3 |
transmembrane and coiled-coil domain family 3 |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of TMCC3 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr12:94,567,122...94,650,557
Ensembl chr12:94,567,122...94,650,557
|
|
G |
TMEM250 |
transmembrane protein 250 |
increases expression |
EXP |
Deoxyglucose results in increased expression of TMEM250 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 9:136,107,767...136,118,875
Ensembl chr 9:136,114,581...136,118,875
|
|
G |
TMEM87A |
transmembrane protein 87A |
increases expression |
EXP |
Deoxyglucose results in increased expression of TMEM87A mRNA |
CTD |
PMID:33770205 |
|
NCBI chr15:42,210,447...42,273,584
Ensembl chr15:42,210,447...42,273,534
|
|
G |
TNF |
tumor necrosis factor |
decreases expression multiple interactions decreases response to substance |
ISO EXP |
Deoxyglucose results in decreased expression of TNF protein Quercetin inhibits the reaction [TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose] Deoxyglucose inhibits the reaction [bisphenol F results in increased secretion of TNF protein]; Quercetin inhibits the reaction [TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose] Deoxyglucose results in decreased susceptibility to TNF protein Deoxyglucose inhibits the reaction [TNF protein results in increased expression of MMP13 protein]; TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]] |
CTD |
PMID:16483873 PMID:21211511 PMID:21778228 PMID:22713545 PMID:23439570 PMID:34147605 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
EXP |
[Deoxyglucose co-treated with demycarosyl-3D-digitoxosylmithramycin SK] results in increased expression of TP53 mRNA; Deoxyglucose promotes the reaction [demycarosyl-3D-digitoxosylmithramycin SK results in increased expression of TP53 mRNA]; TP53 protein inhibits the reaction [Deoxyglucose results in decreased abundance of Adenosine Triphosphate] |
CTD |
PMID:21042727 PMID:26079942 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
multiple interactions |
EXP |
[arsenic trioxide co-treated with Deoxyglucose] results in decreased expression of XIAP protein |
CTD |
PMID:23041229 |
|
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,712...123,913,972
|
|
G |
YARS2 |
tyrosyl-tRNA synthetase 2 |
increases expression |
EXP |
Deoxyglucose results in increased expression of YARS2 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr12:32,746,544...32,755,897
Ensembl chr12:32,727,490...32,755,897
|
|
G |
YES1 |
YES proto-oncogene 1, Src family tyrosine kinase |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of YES1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr18:721,588...812,753
Ensembl chr18:721,588...812,546
|
|
G |
ZBTB1 |
zinc finger and BTB domain containing 1 |
increases expression |
EXP |
Deoxyglucose results in increased expression of ZBTB1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr14:64,503,716...64,533,693
Ensembl chr14:64,503,712...64,533,690
|
|
G |
ZFX |
zinc finger protein X-linked |
increases expression |
EXP |
Deoxyglucose results in increased expression of ZFX mRNA |
CTD |
PMID:33770205 |
|
NCBI chr X:24,148,982...24,216,255
Ensembl chr X:24,149,173...24,216,255
|
|
|
G |
FUT8 |
fucosyltransferase 8 |
multiple interactions |
EXP |
Fucose analog inhibits the reaction [Mersalyl results in decreased activity of FUT8 protein]; Fucose analog inhibits the reaction [p-Chloromercuribenzoic Acid results in decreased activity of FUT8 protein]; Fucose analog inhibits the reaction [Phenylglyoxal results in decreased activity of FUT8 protein]; Fucose analog inhibits the reaction [Pyridoxal Phosphate results in decreased activity of FUT8 protein] |
CTD |
PMID:12770769 |
|
NCBI chr14:65,356,842...65,744,121
Ensembl chr14:65,410,592...65,744,121
|
|
G |
LCT |
lactase |
increases hydrolysis |
ISO |
LCT protein results in increased hydrolysis of Fucose |
CTD |
PMID:14701853 |
|
NCBI chr 2:135,787,850...135,837,184
Ensembl chr 2:135,787,850...135,837,184
|
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO EXP |
baohuoside I results in decreased expression of ABCB11 mRNA; baohuoside I results in decreased expression of ABCB11 protein |
CTD |
PMID:35802278 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
ISO EXP |
baohuoside I results in decreased expression of ABCC2 mRNA; baohuoside I results in decreased expression of ABCC2 protein |
CTD |
PMID:35802278 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
EXP |
baohuoside I results in decreased phosphorylation of AKT1 protein baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:25119583 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
AKT1S1 |
AKT1 substrate 1 |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein] baohuoside I results in decreased phosphorylation of AKT1S1 protein |
CTD |
PMID:25119583 |
|
NCBI chr19:49,869,033...49,878,356
Ensembl chr19:49,869,033...49,878,459
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
increases expression increases secretion |
ISO |
baohuoside I results in increased expression of ALPL mRNA baohuoside I results in increased secretion of ALPL protein |
CTD |
PMID:17764702 PMID:35802278 |
|
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
baohuoside I results in increased expression of BAX protein |
CTD |
PMID:22687635 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression |
EXP |
baohuoside I results in decreased expression of BCL2 protein |
CTD |
PMID:22687635 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
increases expression |
ISO |
baohuoside I results in increased expression of BGLAP mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
decreases phosphorylation multiple interactions |
EXP |
baohuoside I results in decreased phosphorylation of BRAF protein baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of BRAF protein] |
CTD |
PMID:25119583 |
|
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
|
|
G |
CASP3 |
caspase 3 |
increases cleavage increases activity |
EXP |
baohuoside I results in increased cleavage of CASP3 protein baohuoside I results in increased activity of CASP3 protein |
CTD |
PMID:19289254 PMID:22687635 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
increases activity |
EXP |
baohuoside I results in increased activity of CASP8 protein |
CTD |
PMID:19289254 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases activity increases cleavage |
EXP |
baohuoside I results in increased activity of CASP9 protein baohuoside I results in increased cleavage of CASP9 protein |
CTD |
PMID:19289254 PMID:22687635 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
increases expression |
ISO |
baohuoside I results in increased expression of COL1A2 mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
ISO EXP |
baohuoside I results in increased expression of CYP7A1 mRNA; baohuoside I results in increased expression of CYP7A1 protein |
CTD |
PMID:35802278 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of BRAF protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MTOR protein] |
CTD |
PMID:25119583 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] baohuoside I results in decreased phosphorylation of EGFR protein |
CTD |
PMID:25119583 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions |
EXP |
baohuoside I binds to and results in increased degradation of ESR1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [baohuoside I results in increased degradation of ESR1 protein]; ESR1 inhibits the reaction [baohuoside I results in decreased expression of and affects the localization of NR0B2 protein] |
CTD |
PMID:35802278 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
increases secretion |
ISO EXP |
baohuoside I results in increased secretion of GOT1 protein |
CTD |
PMID:35802278 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GPT |
glutamic--pyruvic transaminase |
increases secretion |
ISO EXP |
baohuoside I results in increased secretion of GPT protein |
CTD |
PMID:35802278 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
decreases phosphorylation |
EXP |
baohuoside I results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:25119583 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] baohuoside I results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:25119583 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein] baohuoside I results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:25119583 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
decreases expression |
EXP |
baohuoside I results in decreased expression of MKI67 protein |
CTD |
PMID:25119583 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MTOR protein] baohuoside I results in decreased phosphorylation of MTOR protein |
CTD |
PMID:25119583 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
NOS2 |
nitric oxide synthase 2 |
decreases expression |
EXP |
baohuoside I results in decreased expression of NOS2 |
CTD |
PMID:19289254 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
decreases expression multiple interactions |
ISO EXP |
baohuoside I results in decreased expression of NR0B2 mRNA; baohuoside I results in decreased expression of NR0B2 protein baohuoside I results in decreased expression of and results in decreased activity of and affects the localization of NR0B2 protein; ESR1 inhibits the reaction [baohuoside I results in decreased expression of and affects the localization of NR0B2 protein] |
CTD |
PMID:35802278 |
|
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
decreases expression |
EXP ISO |
baohuoside I results in decreased expression of NR1H4 mRNA; baohuoside I results in decreased expression of NR1H4 protein |
CTD |
PMID:35802278 |
|
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
EXP |
baohuoside I results in increased cleavage of PARP1 protein Dinoprostone inhibits the reaction [baohuoside I results in increased cleavage of PARP1 protein]; PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein] |
CTD |
PMID:19289254 PMID:22687635 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PDPK1 |
3-phosphoinositide dependent protein kinase 1 |
decreases phosphorylation |
EXP |
baohuoside I results in decreased phosphorylation of PDPK1 protein |
CTD |
PMID:25119583 |
|
NCBI chr16:2,538,021...2,603,188
Ensembl chr16:2,537,979...2,603,188
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions |
EXP |
baohuoside I results in decreased expression of PTGS2 [baohuoside I results in decreased expression of PTGS2] which results in decreased abundance of Dinoprostone; PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein] |
CTD |
PMID:19289254 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
SLC10A1 |
solute carrier family 10 member 1 |
increases expression |
ISO EXP |
baohuoside I results in increased expression of SLC10A1 mRNA; baohuoside I results in increased expression of SLC10A1 protein |
CTD |
PMID:35802278 |
|
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
decreases expression |
EXP |
baohuoside I results in decreased expression of SLCO1A1 mRNA |
CTD |
PMID:35802278 |
|
NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
|
|
G |
TNFRSF11B |
TNF receptor superfamily member 11b |
increases expression |
ISO |
baohuoside I results in increased expression of TNFRSF11B mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
decreases expression |
ISO |
baohuoside I results in decreased expression of TNFSF11 mRNA |
CTD |
PMID:17764702 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
VEGFA |
vascular endothelial growth factor A |
decreases expression |
EXP |
baohuoside I results in decreased expression of VEGFA |
CTD |
PMID:19289254 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
AGT |
angiotensinogen |
multiple interactions |
ISO |
phosphoramidon inhibits the reaction [AGT protein results in increased expression of EDNRA protein] |
CTD |
PMID:15007106 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] |
CTD |
PMID:15177934 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
ECE1 |
endothelin converting enzyme 1 |
multiple interactions decreases activity |
ISO |
EDN1 protein inhibits the reaction [phosphoramidon inhibits the reaction [Indomethacin results in increased activity of ECE1 protein]]; phosphoramidon inhibits the reaction [Indomethacin results in increased activity of ECE1 protein]; phosphoramidon inhibits the reaction [Indomethacin results in increased expression of ECE1 protein] phosphoramidon decreases activity of recombinant Ece1 protein in COS cells |
CTD RGD |
PMID:11145282 PMID:16280098 PMID:8034569 |
RGD:728596 |
NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
|
|
G |
EDN1 |
endothelin 1 |
decreases expression multiple interactions |
ISO |
phosphoramidon results in decreased expression of EDN1 protein EDN1 protein inhibits the reaction [phosphoramidon inhibits the reaction [Indomethacin results in increased activity of ECE1 protein]]; EDN1 protein inhibits the reaction [phosphoramidon inhibits the reaction [Indomethacin results in increased expression of EDN1 protein]]; phosphoramidon inhibits the reaction [Indomethacin results in increased expression of EDN1 protein] |
CTD |
PMID:11145282 PMID:16280098 PMID:16391412 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EDNRA |
endothelin receptor type A |
multiple interactions |
ISO |
phosphoramidon inhibits the reaction [AGT protein results in increased expression of EDNRA protein]; phosphoramidon inhibits the reaction [Phenylephrine results in increased expression of EDNRA protein] |
CTD |
PMID:15007106 |
|
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
|
|
G |
EDNRB |
endothelin receptor type B |
increases expression |
ISO |
phosphoramidon results in increased expression of EDNRB protein |
CTD |
PMID:15007106 |
|
NCBI chr13:77,895,481...77,975,527
Ensembl chr13:77,895,481...77,975,529
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] |
CTD |
PMID:15177934 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
phosphoramidon inhibits the reaction [Morphine results in decreased expression of ICAM1 protein alternative form] |
CTD |
PMID:10070497 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
KEL |
Kell metallo-endopeptidase (Kell blood group) |
multiple interactions |
EXP |
KEL protein alternative form binds to and affects the metabolism of phosphoramidon |
CTD |
PMID:15769748 |
|
NCBI chr 7:142,941,114...142,962,363
Ensembl chr 7:142,941,114...142,962,363
|
|
G |
LEP |
leptin |
decreases expression |
ISO |
phosphoramidon results in decreased expression of LEP protein |
CTD |
PMID:16391412 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
CTD |
PMID:15177934 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:15177934 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MME |
membrane metalloendopeptidase |
multiple interactions |
ISO |
phosphoramidon inhibits the reaction [Morphine results in increased activity of MME protein] |
CTD |
PMID:10070497 |
|
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
|
|
G |
NTS |
neurotensin |
multiple interactions |
EXP |
phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein]; phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:15177934 |
|
NCBI chr12:85,874,295...85,882,992
Ensembl chr12:85,874,295...85,882,992
|
|
G |
SELL |
selectin L |
multiple interactions |
ISO |
phosphoramidon inhibits the reaction [Morphine results in decreased expression of SELL protein alternative form] |
CTD |
PMID:10070497 |
|
NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702
|
|
G |
TAC1 |
tachykinin precursor 1 |
multiple interactions |
ISO |
[TAC1 protein co-treated with phosphoramidon] results in increased uptake of Oxygen |
CTD |
PMID:9808699 |
|
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
|
|
|
G |
OAT |
ornithine aminotransferase |
multiple interactions |
ISO |
Rhamnose inhibits the reaction [Cyclic AMP results in increased activity of OAT protein] |
CTD |
PMID:2827574 |
|
NCBI chr10:124,397,303...124,418,923
Ensembl chr10:124,397,303...124,418,976
|
|